Exchange: NASDAQ·Updated 04:23 PM EDT
BFRI logo

BFRI Biofrontera Inc

$1.52
$0.01
(0.66%)
Today
Closed $1.51
$0.01
(0.66%)
After Hours
Reported EarningsAug 13
Mkt Cap$22.58M
Vol549,416.00

About BFRI

Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company focuses on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.
63

Bullish Sentiment

How do you feel about BFRI?

Advertisement|Remove ads.